from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3257c/pmmA

LFCtreatmentdescriptionclass of inhibitor

-0.338

Amikacinug/mL Amikacintranslation

-0.063

Cap5-10ug/mL Capreomycintranslation

-0.419

Rox10-50 ug/mL Roxithromycintranslation

-0.496

SM2-5 ug/mL Streptomycintranslation

-0.681

Tet5-10 ug/mL Tetracyclinetranslation

0.407

Rif0.2-5ug/mL Rifampicintranscription

-0.277

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.793

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.981

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.962

CPZ10-50 ug/mL Chlorpromazinerespiration

1.383

Clofazimine10-13 ug/mL Clofaziminerespiration

0.979

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.578

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.544

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.797

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.846

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.339

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.958

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.062

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.412

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.669

KCN5-20 ug/mL Potassium cyaniderespiration

1.025

NaN30.2-2 mM Sodium aziderespiration

0.149

Nigericin50 uM Nigericinrespiration

1.509

TRC10-150 ug/mL Triclosanrespiration

0.930

TRZ10-25 ug/mL Thioridazinerespiration

-0.489

Valinomycin0.5-10 uM Valinomycinrespiration

0.515

ZnSO42 mM ZnSO4respiration

0.747

menadione6-10 ug/mL Menadionerespiration

0.239

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.270

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.123

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.961

NRP_1Non-replicating persistence stage 1dosRassociated

-0.902

Amp0.2mg/mL AmpicillincellWall

0.082

Cephalexin20-100 ug/mL CephalexincellWall

-0.185

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.588

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.755

EMB10-20 ug/mL EthambutolcellWall

0.198

Eta12-40 ug/mL EthionamidecellWall

0.243

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.206

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.344

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.050

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.173

BZA0.12 mg/mL BenzamidearomaticAmides

-0.538

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.431

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.533

H2O24 mM hydrogen peroxideDNAdamaging

0.103

Levo10 ug/mL LevofloxacinDNAdamaging

-1.214

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.586

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.425

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.470

UVUV-irradiationDNAdamaging

0.597

ARP41-4 ug/mL Antitubercular compound ARP4?

0.026

Antimycin12.5-50 ug/mL Antimycin A?

0.231

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.556

PA_110-50 ug/mL Antitubercular compound PA-1?

0.194

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.791

PA8240.2-2 ug/mL PA-824?

1.021

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.662

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.006

Verapamil50 uM Verapamil?

-0.330

mercaptoethanol2 mM 2-Mercaptoethanol?

0.057

methoxatin10-20 ug/mL Methoxatin?